Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways

por Valle, C, Salvatori, I, Gerbino, V, Rossi, S, Palamiuc, L, René, F, Carrì, M T
Publicado 2014

Pur-alpha functionally interacts with FUS carrying ALS-associated mutations

por Di Salvio, M, Piccinni, V, Gerbino, V, Mantoni, F, Camerini, S, Lenzi, J, Rosa, A, Chellini, L, Loreni, F, Carrì, M T, Bozzoni, I, Cozzolino, M, Cestra, G
Publicado 2015